Dec 04, 2024 Tso lus

PRISYS Daim Ntawv Qhia Txhua Xyoo 2024: Txhim Kho NHP Cov Qauv Thiab Kev Tshawb Fawb Preclinical

PRISYS Biotechzoo siab los qhia txog kev ua tiav thiab kev nce qib uas tau ua hauv 2024 los ntawm peb ib qho ntawm-ib-zoo Tsis-Human Primate (NHP) Translational R & D Center. Nyob rau xyoo tas los no, peb tau ua tiav kev txhawb nqa ntau dua 50 tus neeg koom tes thoob ntiaj teb los ntawm kev muab cov kev pabcuam tshawb fawb zoo, suav nrogKev soj ntsuam kev siv tshuaj, kev soj ntsuam kev nyab xeeb, tshuaj metabolism thiab tshuaj pharmacokinetics (DMPK), kev tshawb fawb biodistribution, thiab IND xa.

 

figure 1

Daim duab 1:PRISYS Txhawb Kev Txhim Kho Tshuaj Ntiaj Teb nrog NHP Cov Qauv thiab Tshuab

 

 

Peb cov qauv NHP tshiab thiab cov thev naus laus zis tau ua kom muaj kev vam meej hauv ntau qhov chaw kho mob, txhawb nqa peb txoj kev mob siab rau kev ua kom ceev cov tshuaj kho mob thiab kev tshawb fawb kev txhais lus.


 

2024 Kev Tshawb Fawb Highlights

 

Xyoo 2024, PRISYS Biotech tau qhia txog kev ntseeg tau thiab ntau yam ntawm peb cov qauv NHP thoob plaws ntau qhov chaw kho mob:

Neuroscience

Immunology

  • Rheumatoid mob caj dab (RA)
  • Atopic Dermatitis (AD)
  • Mob hawb pob
  • Kev mob

Hematology

Metabolism

  • Tsis-Alcoholic Fatty Liver Disease (NAFL)/Non-Alcoholic Steatohepatitis (NASH)
  • Kev rog rog
  • Hom 2 Ntshav Qab Zib

Ophthalmology

  • Glaucoma
  • Retinitis Pigmentosa thiab Neovascularization

 

Kev Tsim Kho Tshiab

Real-Time MRI Navigation (RT-iMRI): Ua kom yooj yim rau kev xa tshuaj zoo los ntawm kev xa khoom zoo (CED) hauv lub hlwb.

AI-Based NHP Behavior Analysis System: Muab kev faib tawm thiab kev ntsuas tus kheej ntawm cov ntaub ntawv coj tus cwj pwm rau kev pom tus kab mob, kev siv tshuaj zoo, thiab kev ntsuas kev nyab xeeb.

 

figure 2

Daim duab 2:Qauv ntawm Atopic March (txuas Atopic Dermatitis thiab Asthma) thiab AI-raws li 3D kom muaj nuj nqis ntawm pruritus hauv AD.

 

 

figure 3

Daim duab 3:BOLD fMRI nrhiav pom qhov mob tshwm sim los ntawm capsaicin irritation.


2025 Pipeline: nthuav NHP Cov Qauv thiab Cov Tshuab

 

Raws li peb saib ua ntej mus rau 2025, PRISYS Biotech tau cog lus los nthuav peb lub peev xwm ntxiv nrog kev qhia txogNHP cov qauv tshiab thiab cov thev naus laus zis siab heev. Cov kev muab tshiab no yog tsim los daws cov teeb meem tshwm sim thiab ua kom cov tshuaj txhim kho hauv cov chaw kho mob tseem ceeb:

Neuroscience

  • Alzheimer's Disease
  • Kev Ntsuam Xyuas Kev Mob Siab

Immunology

  • Mob plab hnyuv MRI Scoring rau kab mob plab hnyuv (IBD)
  • DermaLab Daim tawv nqaij Analysis rau Psoriasis
  • Accelerated Multiple Sclerosis (MS) Kev Txhim Kho

Metabolism

  • Progressive thiab Chronic Heart Failure
  • Lub raum tsis ua haujlwm
  • Mob siab

Ua pa

 

Tswv yim Technology

Nasal-to-Brain (N2B) Tshuaj xa cov tshuaj

Peb lub tswv yim N2B platform yog tsim los txhim kho cov tshuaj xa mus rau lub hauv paus paj hlwb, muab txoj hauv kev zoo rau kev kho cov kab mob neurological thiab neurodegenerative.

 


 

Tsav Innovation hauv Preclinical Research

 

Ntawm PRISYS Biotech, peb tau mob siab rau muab peb cov koom tes thoob ntiaj teb nrogtxhim khu kev qha, zoo NHP qauv thiab cov thev naus laus zislos txhawb kev tshawb fawb preclinical thiab kev tsim tshuaj. Peb txuas ntxiv kev siv zog los nthuav peb cov khoom thiab txhim kho cov qauv kev ntseeg siab los daws cov kev xav tau hloov zuj zus ntawm kev lag luam tshuaj thiab biotechnology.

Peb caw peb cov neeg koom tes thiab cov neeg koom tes los tshawb nrhiav qhov muaj peev xwm ua haujlwm nrog PRISYS Biotech hauv 2025 thiab dhau mus. Ua ke, peb tuaj yeem tsav kev tsim kho tshiab thiab coj cov kev kho mob hloov pauv rau cov neeg mob thoob ntiaj teb.

Yog xav paub ntxiv, thov hu rau peb lossis mus saib peb lub vev xaib www.prisysbiotech.com.

Xa kev nug

Tsev

Xov tooj

Tug

Kev nug